![AB1164 A COST PER RESPONDER ANALYSIS OF ABATACEPT VERSUS ADALIMUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AMONG PATIENTS WITH SHARED EPITOPE (SE) POSITIVITY FROM A UNITED STATES PAYER PERSPECTIVE | Annals of AB1164 A COST PER RESPONDER ANALYSIS OF ABATACEPT VERSUS ADALIMUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AMONG PATIENTS WITH SHARED EPITOPE (SE) POSITIVITY FROM A UNITED STATES PAYER PERSPECTIVE | Annals of](https://ard.bmj.com/content/annrheumdis/79/Suppl_1/1872.1/F1.large.jpg)
AB1164 A COST PER RESPONDER ANALYSIS OF ABATACEPT VERSUS ADALIMUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AMONG PATIENTS WITH SHARED EPITOPE (SE) POSITIVITY FROM A UNITED STATES PAYER PERSPECTIVE | Annals of
![Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical Trials - Cordisco - 2022 - ACR Open Rheumatology - Wiley Online Library Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical Trials - Cordisco - 2022 - ACR Open Rheumatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/150bf0c5-06d8-47e5-bf38-3ce960e8094b/acr211468-fig-0003-m.jpg)
Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical Trials - Cordisco - 2022 - ACR Open Rheumatology - Wiley Online Library
![Efficacy of Leflunomide 100mg Weekly Compared to Low Dose Methotrexate in Patients With Active Rheumatoid Arthritis. Double Blind, Randomized Clinical Trial | Reumatología Clínica Efficacy of Leflunomide 100mg Weekly Compared to Low Dose Methotrexate in Patients With Active Rheumatoid Arthritis. Double Blind, Randomized Clinical Trial | Reumatología Clínica](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2173574312001220:gr3.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9184xd8ym1IgxXJ6I4p31f1upH6Ra9/FExf9t4wRA9EIUj/ul6vGgHA8hYkucearNprtlttszIk8yK67g/MfIfmCIoUb29oIgEBBXPdGRh9OswMX7XdPU6HkmeMo6/TnY2FoMuHRIzoeV0W9WQZ9saRZZBryWLZSWt3szdrf2rISV5GGuH1eOv4L7au661EUAIdzMfwac2zGGR+aQkESWVz3hpnY8xKBfr2m83Ea80aJbCBMel8LYGepqvfW9xws7kkOU3xOQ73k9ZfArwYatZs=)
Efficacy of Leflunomide 100mg Weekly Compared to Low Dose Methotrexate in Patients With Active Rheumatoid Arthritis. Double Blind, Randomized Clinical Trial | Reumatología Clínica
![Cureus | A Meta-Analysis Evaluating the Effectiveness and Safety of Upadacitinib in Treating Rheumatoid Arthritis in Patients With Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs | Article Cureus | A Meta-Analysis Evaluating the Effectiveness and Safety of Upadacitinib in Treating Rheumatoid Arthritis in Patients With Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs | Article](https://assets.cureus.com/uploads/figure/file/528399/lightbox_83abd0708b6011edb23a657b2414bbcf-Untitled-1.png)
Cureus | A Meta-Analysis Evaluating the Effectiveness and Safety of Upadacitinib in Treating Rheumatoid Arthritis in Patients With Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs | Article
![Efficacy of Leflunomide 100mg Weekly Compared to Low Dose Methotrexate in Patients With Active Rheumatoid Arthritis. Double Blind, Randomized Clinical Trial | Reumatología Clínica Efficacy of Leflunomide 100mg Weekly Compared to Low Dose Methotrexate in Patients With Active Rheumatoid Arthritis. Double Blind, Randomized Clinical Trial | Reumatología Clínica](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2173574312001220:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9184xd8ym1IgxXJ6I4p31f1upH6Ra9/FExf9t4wRA9EIUj/ul6vGgHA8hYkucearNprtlttszIk8yK67g/MfIfmCIoUb29oIgEBBXPdGRh9OswMX7XdPU6HkmeMo6/TnY2FoMuHRIzoeV0W9WQZ9saRZZBryWLZSWt3szdrf2rISV5GGuH1eOv4L7au661EUAIdzMfwac2zGGR+aQkESWVz3hpnY8xKBfr2m83Ea80aJbCBMel8LYGepqvfW9xws7kkOU3xOQ73k9ZfArwYatZs=)
Efficacy of Leflunomide 100mg Weekly Compared to Low Dose Methotrexate in Patients With Active Rheumatoid Arthritis. Double Blind, Randomized Clinical Trial | Reumatología Clínica
![JCM | Free Full-Text | Clinical Trials in Chronic Arthritic Diseases with Underestimated Impact of Placebo Effects on Study Size Calculation JCM | Free Full-Text | Clinical Trials in Chronic Arthritic Diseases with Underestimated Impact of Placebo Effects on Study Size Calculation](https://pub.mdpi-res.com/jcm/jcm-12-00429/article_deploy/html/images/jcm-12-00429-g002.png?1672908398)
JCM | Free Full-Text | Clinical Trials in Chronic Arthritic Diseases with Underestimated Impact of Placebo Effects on Study Size Calculation
![Which ACR Response Definition Should Be Used for Disease Activity Claims in Approval Studies of Rheumatoid Arthritis? A Systematic Evaluation - ACR Meeting Abstracts Which ACR Response Definition Should Be Used for Disease Activity Claims in Approval Studies of Rheumatoid Arthritis? A Systematic Evaluation - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2022/09/1291908_2.jpg)
Which ACR Response Definition Should Be Used for Disease Activity Claims in Approval Studies of Rheumatoid Arthritis? A Systematic Evaluation - ACR Meeting Abstracts
![Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study | SpringerLink Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40744-021-00396-8/MediaObjects/40744_2021_396_Fig2_HTML.png)
Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study | SpringerLink
![JCM | Free Full-Text | Clinical Trials in Chronic Arthritic Diseases with Underestimated Impact of Placebo Effects on Study Size Calculation JCM | Free Full-Text | Clinical Trials in Chronic Arthritic Diseases with Underestimated Impact of Placebo Effects on Study Size Calculation](https://www.mdpi.com/jcm/jcm-12-00429/article_deploy/html/images/jcm-12-00429-g001.png)
JCM | Free Full-Text | Clinical Trials in Chronic Arthritic Diseases with Underestimated Impact of Placebo Effects on Study Size Calculation
![Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis | Arthritis Research & Therapy | Full Text Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-020-02346-1/MediaObjects/13075_2020_2346_Fig1_HTML.png)